Evidence map›Paper›PMID 34285296›Full record

ArticleScientific reports2021

In vitro evidence for the involvement of H

Rosangela Montanaro, Alessio D'Addona, Andrea Izzo, Carlo Ruosi, Vincenzo Brancaleone

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. CuNanoscale advances · 2023
    Article
  4. Repurposed and investigational disease-modifying drugs in osteoarthritis (DMOADs).Therapeutic advances in musculoskeletal disease · 2022
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Rosangela Montanaro *Department of Science, University of Basilicata, Via Ateneo Lucano, 85100, Potenza, Italy.
Alessio D'Addona *Humanitas Clinical and Research Center-IRCCS, Via Alessandro Manzoni 56, 20089, Rozzano, Italy. alessio.daddona@gmail.com.
Andrea IzzoDepartment of Public Health, Section of Orthopaedics and Trauma Surgery, AOU Federico II, School of Medicine and Surgery, Federico II" of Naples, Naples, Italy.
Carlo RuosiDepartment of Public Health, Section of Orthopaedics and Trauma Surgery, AOU Federico II, School of Medicine and Surgery, Federico II" of Naples, Naples, Italy.
Vincenzo BrancaleoneDepartment of Science, University of Basilicata, Via Ateneo Lucano, 85100, Potenza, Italy. vincenzo.brancaleone@unibas.it.
Federico II University Hospital · ITUniversity of Basilicata · ITIstituti di Ricovero e Cura a Carattere Scientifico · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clodronate is a bisphosphonate agent commonly used as anti-osteoporotic drug. Throughout its use, additional anti-inflammatory and analgesic properties have been reported, although the benefits described in the literature could not solely relate to their inhibition of bone resorption. Thus, the purpose of our in vitro study is to investigate whether there are underlying mechanisms explaining the anti-inflammatory effect of clodronate and possibly involving hydrogen sulphide (H

Indexed as

Anti-Inflammatory AgentsCell LineClodronic AcidCytokinesDown-RegulationGene Expression RegulationHumansHydrogen SulfideNitric Oxide Synthase Type IISignal TransductionSynoviocytesTumor Necrosis Factor-alphaAnti-Inflammatory AgentsClodronic AcidCytokinesHydrogen SulfideNitric Oxide Synthase Type IINOS2 protein, humanTumor Necrosis Factor-alpha

Identifiers

PMID34285296
PMCPMC8292495
OpenAlexW3184691646

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.